New Strategies to Kill Metabolically-Dormant Cells Directly Bypassing the Need for Active Cellular Processes
Antibiotic therapy failure is often caused by the presence of persister cells, which are metabolically-dormant bacteria capable of surviving exposure to antimicrobials. Under favorable conditions, persisters can resume growth leading to recurrent infections. Moreover, several studies have indicated...
| 主要な著者: | , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
MDPI AG
2023-06-01
|
| シリーズ: | Antibiotics |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2079-6382/12/6/1044 |